Find News

Filter articles

Applied Filters

Showing 81 to 90 of 909 results

Takeda sues Mylan over gout generic

US05-12-2019Saman Javed

Takeda has sued Mylan for patent infringement and breach of a licencing agreement over Takeda’s Colcrys drug.

Generic drugmaker to pay $3m antitrust fine

US05-12-2019Sarah Morgan

New Jersey-based generic drugmaker Rising Pharmaceuticals has admitted to conspiring to fix prices and allocate customers for a generic hypertension drug.

LSPN Europe: understand our business models, say in-house lawyers

26-11-2019Tom Phillips

The best lawyers acting for life sciences companies make sure they fully understand their clients’ business models, said in-house counsel at Life Sciences Patent Network 2019.

LSPN Europe: new challenges for drug patent owners in Russia

Russia21-11-2019Rory O'Neill

Russian drug patent owners are being forced to come up with novel solutions to combat generic manufacturers trying to clear the way for competitor medicines.

Drop prices or lose patent rights, say White House hopefuls

US21-11-2019Rory O'Neill

US presidential candidates Bernie Sanders and Cory Booker have tabled a bill that would force drug companies to adhere to government-set prices-or risk losing patent exclusivity.

Russian government approves compulsory drug licensing bill

Russia19-11-2019Rory O'Neill

The Russian government has endorsed legislation that would allow it to employ compulsory drug licensing in emergencies.

Chinese state-owned chemical firm in fungicide patent suit

China, US14-11-2019Rory O'Neill

A Chinese state-owned chemical firm is suing US crop protection products company Atticus for patent infringement.

Novartis acquires Japanese generics business in €400m deal

Japan12-11-2019Rory O'Neill

Novartis has agreed to buy the Japanese business of South African generics manufacturer Aspen Pharmacare for a potential €400 million.

Pfizer and Sun settle Bosulif dispute

06-11-2019Rory O'Neill

Pfizer and Indian drugmaker Sun Pharmaceuticals have agreed to settle patent litigation over a generic version of Pfizer’s leukaemia drug, Bosulif.

Takeda sells generics portfolio to Stada for $660m

Germany, Russia06-11-2019Saman Javed

German pharmaceutical company Stada Arzneimittel has acquired a portfolio of products from Takeda for $660 million.

Showing 81 to 90 of 909 results